Co-Administration of Vadimezan and Recombinant Coagulase-NGR Inhibits Growth of Melanoma Tumor in Mice

Purpose: Tumor vascular targeting appeared as an appealing approach to fight cancer, though, the results from the clinical trials and drugs in the market were proved otherwise. The promise of anti-angiogenic therapy as the leading tumor vascular targeting strategy was negatively affected with the di...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Adv Pharm Bull
Autors principals: Daei Farshchi Adli, Amir, Jahanban-Esfahlan, Rana, Seidi, Khaled, Farajzadeh, Davoud, Behzadi, Ramezan, Zarghami, Nosratollah
Format: Artigo
Idioma:Inglês
Publicat: Tabriz University of Medical Sciences 2021
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8046391/
https://ncbi.nlm.nih.gov/pubmed/33880362
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.34172/apb.2021.037
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars